Literature DB >> 28872022

Lung cancer.

Richard Barnett.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28872022     DOI： 10.1016/S0140-6736(17)32243-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs.

Authors:  Rongmu Xia; Guojun Geng; Xiuyi Yu; Zhong Xu; Jing Guo; Hongming Liu; Ning Li; Ziyan Li; Yingli Li; Xiaofang Dai; Qicong Luo; Jie Jiang; Yanjun Mi
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751

Review 2.  Rationale for Lung Adenocarcinoma Prevention and Drug Development Based on Molecular Biology During Carcinogenesis.

Authors:  Hongming Zhang; Liting Guo; Jibei Chen
Journal:  Onco Targets Ther       Date:  2020-04-14       Impact factor: 4.147

3.  Long intergenic non-coding RNA Linc00485 promotes lung cancer progression by modulating miR-298/c-Myc axis.

Authors:  Zhenyang Zhang; Wenwei Lin; Yuhan Lin; Mingqiang Kang; Jiafu Zhu; Zhangwei Tong; Long Wu; Jianhai Sun; Jiangbo Lin
Journal:  J Cell Mol Med       Date:  2020-11-25       Impact factor: 5.310

4.  A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer.

Authors:  Wenhai Huang; Hao Huang; Shuishen Zhang; Xueping Wang; Juan Ouyang; Zhichao Lin; Peisong Chen
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

5.  Functions and clinical significance of KLRG1 in the development of lung adenocarcinoma and immunotherapy.

Authors:  Xiaodong Yang; Yuexin Zheng; Zhihai Han; Xiliang Zhang
Journal:  BMC Cancer       Date:  2021-06-29       Impact factor: 4.430

6.  Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.

Authors:  Yujiao Deng; Peng Zhao; Linghui Zhou; Dong Xiang; Jingjing Hu; Yu Liu; Jian Ruan; Xianghua Ye; Yi Zheng; Jia Yao; Zhen Zhai; Shuqian Wang; Si Yang; Ying Wu; Na Li; Peng Xu; Dai Zhang; Huafeng Kang; Jun Lyu; Zhijun Dai
Journal:  J Hematol Oncol       Date:  2020-07-20       Impact factor: 17.388

7.  Loss of CDKN2A at chromosome 9 has a poor clinical prognosis and promotes lung cancer progression.

Authors:  Wei Liu; Congwen Zhuang; Tengfei Huang; Shengsheng Yang; Meiqing Zhang; Baoquan Lin; Yi Jiang
Journal:  Mol Genet Genomic Med       Date:  2020-11-06       Impact factor: 2.183

8.  A novel circular RNA, hsa_circ_0030998 suppresses lung cancer tumorigenesis and Taxol resistance by sponging miR-558.

Authors:  Xiaoping Li; Yiling Feng; Bo Yang; Ting Xiao; Haixia Ren; Xi Yu; Lei Li; Mingjiang Li; Weidong Zhang
Journal:  Mol Oncol       Date:  2021-02-10       Impact factor: 6.603
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.